Cargando…

Effects of zinc sulfate on schizophrenia symptoms in patients undergoing atypical antipsychotic pharmacotherapy

INTRODUCTION: It has been noticed that inadequate levels of zinc (Zn) can have adverse effects on the nervous system, which in turn leads to cognitive disorders. The present study was conducted to determine the effects of Zn sulfate on eliminating the symptoms of schizophrenia. METHODOLOGY: This stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behrouzian, Forouzan, Nazarinasab, Masoumeh, Sadegh, Amirali Moghadam, Abdi, Layla, Sabzevarizadeh, Mansooreh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041027/ https://www.ncbi.nlm.nih.gov/pubmed/36994060 http://dx.doi.org/10.4103/jfmpc.jfmpc_1034_22

Ejemplares similares

Investigating the efficacy of Ginkgo biloba on the cognitive function of patients undergoing treatment with electric shock: a double-blind clinical trial
por: Nazarinasab, Masoumeh, et al.
Publicado: (2022)

Evaluating the Effect of Melatonin on Positive and Negative Symptoms of Schizophrenic Patients: A Randomized Placebo-Controlled Study
por: Behrouzian, Forouzan, et al.
Publicado: (2023)

The Effectiveness of Topiramate in the Treatment of Amphetamine and Methamphetamine Use Disorder: A Randomized Controlled Trial
por: Moghaddam Sadegh, Amirali, et al.
Publicado: (2023)

Investigating the effect of magnesium supplement in patients with major depressive disorder under selective serotonin reuptake inhibitor treatment
por: Nazarinasab, Masoumeh, et al.
Publicado: (2022)

The mediating role of self-compassion in the relationship between positive reactivity, negative reactivity, and perfectionism with disordered eating
por: Mousavi Asl, Esmaeil, et al.
Publicado: (2021)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Severity in schizophrenia patients receiving atypical antipsychotic medications
por: Alam Fatmi1j, Syed Meraj, et al.
Publicado: (2022)

Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside
por: Shad, Mujeeb U.
Publicado: (2021)

Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics
por: Sikirica, Vanja, et al.
Publicado: (2012)

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2006)

Association of Typical versus Atypical Antipsychotics with Symptoms and Quality of Life in Schizophrenia
por: Fujimaki, Koichiro, et al.
Publicado: (2012)

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)

Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
por: Khasawneh, Fadi T., et al.
Publicado: (2014)

A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
por: Gilca, Marilena, et al.
Publicado: (2014)

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia
por: MacEwan, Joanna P., et al.
Publicado: (2016)

Pharmacotherapy for treatment-resistant schizophrenia
por: Mcilwain, Meghan E, et al.
Publicado: (2011)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs
por: Kucharska-Pietura, Katarzyna, et al.
Publicado: (2012)

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics
por: McEvoy, Joseph, et al.
Publicado: (2013)

Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2012)

Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics
por: Kang, Shi Hyun, et al.
Publicado: (2015)

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
por: O’Day, Ken, et al.
Publicado: (2013)

Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
por: Chen, Yi-Lung, et al.
Publicado: (2018)

Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020)

Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
por: Kirino, Eiji
Publicado: (2017)

Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
por: Kositsyn, Yuriy M., et al.
Publicado: (2023)

Validity and reliability: The psychometric properties of the Persian version of Short Form of the Impulsiveness Questionnaire UPPS-P in Iran
por: Behrouzian, Forouzan, et al.
Publicado: (2022)

Serum substance P levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics
por: Nagamine, Takahiko
Publicado: (2008)

Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics
por: Gautam, Shiv, et al.
Publicado: (2011)

Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
por: Choi, Kwang H, et al.
Publicado: (2009)

Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorder
Publicado: (2012)

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
por: Boonlue, Tuanthon, et al.
Publicado: (2016)

Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
por: Yu, Zhi-min, et al.
Publicado: (2019)

Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil
por: Barbosa, Wallace Breno, et al.
Publicado: (2018)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
por: Boiko, Anastasiia S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cjt9bku8hstkm8bnrj4fb0dgmi